Announcements Trials

Browse Landscape

Phase

Status

Completed 7 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 80 Rectal Neoplasms 40 Colonic Neoplasms 34 Pancreatic Neoplasms 27 Stomach Neoplasms 22 Carcinoma, Hepatocellular 21 Breast Neoplasms 21 Esophageal Neoplasms 20 Neoplasm Metastasis 18 Nasopharyngeal Carcinoma 15 Esophageal Squamous Cell Carcinoma 13 Neoplasms 7 Head and Neck Neoplasms 7 Liver Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Carcinoma, Squamous Cell 5 Anus Neoplasms 5 Adenocarcinoma Of Esophagus 5 Nasopharyngeal Neoplasms 4 Inflammatory Breast Neoplasms 4 Cholangiocarcinoma 4 Recurrence 3 Gallbladder Neoplasms 3 Breast Neoplasms, Male 3 Bile Duct Neoplasms 3 Solid Tumors 2 Ovarian Neoplasms 2 Neutropenia 2 Neoplasms, Unknown Primary 2 Laryngeal Neoplasms 2

Interventions

dehydroftorafur 1 Taxes 1 Radiotherapy, Intensity-Modulated 1 Radiation 1 Platinum 1 Paclitaxel 1 Immune Checkpoint Inhibitors 1 Fluorouracil 1 Cisplatin 1 Chemoradiotherapy 1 Carboplatin 1 Capecitabine 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Anal Canal Carcinoma × Fluorouracil × Clear all

NCT02560298 2023-06-22

InterAACT

Eastern Cooperative Oncology Group

Phase 2 Unknown

Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡